icon-folder.gif   Conference Reports for NATAP  
 
  IDSA/IDWeek
2015, October 7-11
San Diego
Back grey_arrow_rt.gif
 
 
 
Ledipasvir/Sofosbuvir Is Safe and Effective for the Treatment of Patients with Genotype 1 Chronic HCV Infection in Both HCV Mono- and HIV/HCV Coinfected Patients
 
 
  Reported by Jules Levin
IDSA 2015 Oct 7-11 San Diego, CA
 
S Naggie1, C Cooper2, P Kwo3, K Kowdley4, S Naik5, M Natha5, LM Stamm5, PS Pang5, Mark Sulkowski6
1Duke Clinical Research Institute, Infectious Diseases Research, Durham, NC; 2The Ottawa Hospital and Regional Hepatitis Program, Ottawa, ON; 3Indiana University, Division of Gastroenterology/Hepatology, Indianapolis, IN; 4Swedish Liver Center, Department of Gastroenterology/Hepatology, Seattle, WA; 5Gilead Sciences, Inc., Foster City, CA; 6Johns Hopkins University School of Medicine, Baltimore, MD

IDSA1.gif

IDSA2.gif

IDSA3.gif

IDSA4.gif

IDSA5.gif

IDSA6.gif

IDSA7.gif

IDSA8.gif

IDSA9.gif

IDSA10.gif

IDSA11.gif

IDSA12.gif

IDSA13.gif

IDSA14.gif